September 5, 2025
See all results
Balancing the Risks and Benefits of Medications
Newsletter
WEBINARS
DONATE
ABOUT
About MedShadow
Our Team
Foundation Board
Health and Medical Advisory Panel
Podcast
MedShadow In The News
ARTICLES
FDA Drug Recalls and Warnings: Recalls for Glaucoma Eye Medications and Allergy Eye Drops
INVESTIGATING GENERICS: Healthcare Providers Call Out Issues With Generic ADHD Meds
Drug Recalls in America: How They Work, Where They Fail, and How You Can Protect Yourself
The FDA’s Drug Adverse Event Database Is Now Updated in Real Time: Here’s How to Use It
New Articles
Health Topics
Conditions
Medications
Wellness
Culture Desk
VIDEOS
VIDEOS
FDA Drug Recalls and Warnings: Recalls for Glaucoma Eye Medications and Allergy Eye Drops
INVESTIGATING GENERICS: Healthcare Providers Call Out Issues With Generic ADHD Meds
Drug Recalls in America: How They Work, Where They Fail, and How You Can Protect Yourself
The FDA’s Drug Adverse Event Database Is Now Updated in Real Time: Here’s How to Use It
Can I Take Prilosec with Levothyroxine?
Medical Animation Videos
Patient Story Videos
Nutrition Videos
PODCAST
PODCAST
Preventable Illnesses: Lifestyle Choices Over Medication
Childhood Asthma and Obesity: The Road to Resilience
Food As Fuel: Managing Sugar Cravings to Fight Inflammation
Creativity in Veganism, and Discovering Vegan Life Balance
Preventative Senior Fitness, Super-Agers, and Trusting Your Body
INFOGRAPHICS
Login / Signup
Search
Home
Features
FDA
Random
Latest
Oldest
Random
A to Z
FDA
News
FDA Bolsters NSAID Warnings on Heart, Stroke Risk
Jonathan Block
Quick Hits
Quick Hits: FDA Breast Cancer Treatment & More
Jonathan Block
FDA
Why Isn’t the FDA Tougher on Tainted Supplements?
Jonathan Block
News
FDA
Quick Hits
Quick Hits: FDA Threatens E-Cig Manufacturers & More
Jonathan Block
E-Cigarette News
FDA Looking Into New Concern With E-Cigs: Seizures
Jonathan Block
Opioid News
FDA Requiring Long-Term Research of OxyContin Use
Suzanne B. Robotti
News
FDA
FDA Approves Praxbind to Reverse Blood Thinner’s Effect
Alanna McCatty
Resources
Drug Classification Schedule of Medicines During Pregnancy
Medshadow Staff
FDA
Weighing Risks and Benefits of Opana ER
Suzanne B. Robotti
Antidepressants and Anxiety Meds
Tianeptine Dangerous, FDA Says
Emma Yasinski
Prescription
5 Ideas To Make Prescription Drugs Safer
Suzanne B. Robotti
Diabetes
FDA Approves Tresiba
Alanna McCatty
FDA
FDA Again Delays Rule on New Safety Warnings for Generic Labels
Jonathan Block
FDA
Are Consumers Getting The Message About Risks In Drug Ads?
Jonathan Block
FDA
Advice for FDA Drug Approvals
Suzanne B. Robotti
FDA
The FDA’s Better Side Effects FAERS Database
Suzanne B. Robotti
FDA
What Happens When The FDA Is Addicted To The Drug Industry?
Jonathan Block
Tests and Testing
Health Pulse
FDA
Is That New Drug Better? A Comparative Look
Jonathan Block
Healthy Skeptic 2
Restasis: When Advertising Outweighs Research and Common Sense
Suzanne B. Robotti
FDA
Clinical Trial Research Phase Studies
Medshadow Staff
Load More
ABOUT
About MedShadow
Our Team
Foundation Board
Health and Medical Advisory Panel
Podcast
MedShadow In The News
ARTICLES
New Articles
Health Topics
Conditions
Medications
Wellness
Culture Desk
VIDEOS
Medical Animation Videos
Patient Story Videos
Nutrition Videos
PODCAST
INFOGRAPHICS
Newsletter
WEBINARS
DONATE
Newsletter
WEBINARS
JOIN
Start typing to see results or hit ESC to close
Zyrtec
PBMs
Zyvox
pharmacies
peer review process
See all results
Username
Password
Remember Me
Sign In
Lost password?
Create an account
Enter username or email
Cancel
x